Background and Aims
Methods
Results
Conclusions
Abbreviations:
LHM (laparoscopic Heller myotomy), LOS (length of stay), NRD (National Readmission Database), PD (pneumatic dilation), POEM (peroral endoscopic myotomy)Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Gastrointestinal EndoscopyReferences
- Motor disorders of the esophagus.N Engl J Med. 2010; 301: 184-192
- Achalasia: physiology and diagnosis.Ann N Y Acad Sci. 2020; 1482: 85-94
- The cost of achalasia: quantifying the effect of symptomatic disease on patient cost burden, treatment time, and work productivity.Surg Innovat. 2010; 17: 291-294
- Achalasia.Lancet. 2014; 383: 83-93
- Population trends in achalasia diagnosis and management: a changing paradigm.Dis Esophagus. 2021; 32: 1-6
- Changing trends in age, gender, racial distribution and inpatient burden of achalasia.Gastroenterol Res. 2017; 10: 70-77
- Rehospitalization, treatment, and resource use after inpatient admission for achalasia in the USA.Dig Dis Sci. 2021; 66: 4149-4158
Gaber CE, Eluri S, Cotton CC, et al. Epidemiologic and economic burden of achalasia in the United States. Clin Gastroenterol Hepatol 2022; 20:342-52.
HCUP Nationwide Readmissions Database (NRD). Healthcare Cost and Utilization Project (HCUP). 2016, 2017, 2018 and 2019. Rockville, MD: Agency for Healthcare Research and Quality. Available at: www.hcup-us.ahrq.gov/nrdoverview.jsp. Retrieved March 19, 2022.
- Hospitalization for achalasia in the United States 1997-2006.Dig Dis Sci. 2009; 54: 1680-1685
- Hospitalization for esophageal achalasia in the United States.World J Gastrointest Endosc. 2015; 7: 1096
- Surgery for benign esophageal disorders in the US: risk factors for complications and trends of morbidity.Surg Endosc. 2018; 32: 3675-3682
Kohli DR, Kennedy KF, Desai M, et al. Safety of endoscopic gastrostomy tube placement compared with radiologic or surgical gastrostomy: nationwide inpatient assessment. Gastrointest Endosc 2021;93:1077-85.
- Safety of endoscopy for hospitalized patients with acute myocardial infarction: a national analysis.Am J Gastroenterol. 2020; 115: 376-380
- Incidence, reasons, and risk factors for readmission after surgery for benign distal esophageal disease.Surgery. 2016; 160: 599-606
Li H, Peng W, Huang S, et al. The 2 years’ long-term efficacy and safety of peroral endoscopic myotomy for the treatment of achalasia: a systematic review. J Cardiothorac Surg 2019;14:1-8.
- Peroral endoscopic myotomy for esophageal achalasia: outcomes of the first 100 patients with short-term follow-up.Ann Surg. 2016; 263: 82-87
Inoue H, Sato H, Ikeda H, et al. Per-oral endoscopic myotomy: a series of 500 patients. J Am Coll Surg 2015;221:256-64.
- Effect of peroral endoscopic myotomy vs pneumatic dilation on symptom severity and treatment outcomes among treatment-naive patients with achalasia: a randomized clinical trial.JAMA. 2019; 322: 134-144
- Peroral endoscopic myotomy (POEM) leads to similar results in patients with and without prior endoscopic or surgical therapy.Surg Endosc. 2015; 29: 1064-1070
- Effect of peroral endoscopic myotomy in achalasia patients with failure of prior pneumatic dilation: a prospective case-control study.J Gastroenterol Hepatol. 2014; 29: 1609-1613
- Peroral endoscopic myotomy (POEM) is safe and effective in the setting of prior endoscopic intervention.J Gastrointest Surg. 2013; 17: 1188-1192
Article info
Publication history
Publication stage
In Press Journal Pre-ProofFootnotes
DISCLOSURE: The following authors disclosed financial relationships: P. Jirapinyo: Research support from Apollo Endosurgery, Fractyl, and GI Dynamics; consultant for Endogastric Solutions and GI Dynamics; honorarium from Obalon Therapeutics; in-kind support from USGI Medical (equipment support). C. C. Thompson: Consultant for Apollo Endosurgery, Boston Scientific, Fujifilm, GI Dynamics, Lumendi, Olympus, USGI Medical, Medtronic; Fractyl, Envision Endoscopy, Enterasense, and GI Windows; research support from Apollo Endosurgery, Boston Scientific, Fujifilm, GI Dynamics, Lumendi, Olympus, USGI Medical, Aspire Bariatrics, and Erbe; general partner for BlueFlame Healthcare; founder of and board member for Envision Endoscopy, Enterasense, and GI Windows. All other authors disclosed no financial relationships.
